Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Central serous chorioretinopathy: An evidence-based treatment guideline
HMA Feenstra, EHC Van Dijk, CMG Cheung… - Progress in Retinal and …, 2024 - Elsevier
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision
loss due to macular subretinal fluid leakage and it is often associated with reduced vision …
loss due to macular subretinal fluid leakage and it is often associated with reduced vision …
[HTML][HTML] Central serous chorioretinopathy: towards an evidence-based treatment guideline
TJ Van Rijssen, EH Van Dijk, S Yzer… - Progress in retinal and …, 2019 - Elsevier
Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily
affecting men 20–60 years of age. To date, no consensus has been reached regarding the …
affecting men 20–60 years of age. To date, no consensus has been reached regarding the …
Central serous chorioretinopathy: a review
AT Fung, Y Yang, AW Kam - Clinical & experimental …, 2023 - Wiley Online Library
Central serous chorioretinopathy (CSC) is the fourth most common non‐surgical retinopathy
associated with fluid leakage. The pathogenesis is not yet completely understood, but …
associated with fluid leakage. The pathogenesis is not yet completely understood, but …
Central serous chorioretinopathy: Treatment
JB Park, K Kim, MS Kang, ES Kim… - Taiwan Journal of …, 2022 - journals.lww.com
Central serous chorioretinopathy (CSC) is a pachychoroid spectrum disease characterized
by serous detachment of the neurosensory retina with subretinal fluid in young and middle …
by serous detachment of the neurosensory retina with subretinal fluid in young and middle …
[HTML][HTML] Photodynamic therapy with verteporfin for chronic central serous chorioretinopathy: a review of data and efficacy
P Iacono, S Da Pozzo, M Varano, M Parravano - Pharmaceuticals, 2020 - mdpi.com
Central serous chorioretinopathy represents the fourth most frequent retinal disorder,
occurring especially in young age. Central serous chorioretinopathy is mainly characterized …
occurring especially in young age. Central serous chorioretinopathy is mainly characterized …
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
TJ van Rijssen, EHC van Dijk, G Dijkman… - Graefe's Archive for …, 2018 - Springer
Purpose To identify characteristics of Caucasian chronic central serous chorioretinopathy
(cCSC) patients without a complete resolution of subretinal fluid (SRF) after reduced-settings …
(cCSC) patients without a complete resolution of subretinal fluid (SRF) after reduced-settings …
[HTML][HTML] Current pharmacological treatment options for central serous chorioretinopathy: a review
Central serous chorioretinopathy (CSC) is a common cause of visual impairment in patients
generally aged 20 to 60 and it is characterized by acute or chronic neurosensory …
generally aged 20 to 60 and it is characterized by acute or chronic neurosensory …
Comparison of short-term efficacy between oral spironolactone treatment and photodynamic therapy for the treatment of nonresolving central serous chorioretinopathy
JH Lee, SC Lee, H Kim, CS Lee - Retina, 2019 - journals.lww.com
Purpose: To compare the short-term therapeutic efficacy of oral spironolactone treatment
with that of half-dose photodynamic therapy (PDT) in patients with nonresolving central …
with that of half-dose photodynamic therapy (PDT) in patients with nonresolving central …
Short term presence of subretinal fluid in central serous chorioretinopathy affects retinal thickness and function
Background: Acute central serous chorioretinopathy (CSCR), with subretinal fluid (SRF)
resolving spontaneously within a few months from disease onset, has been considered as a …
resolving spontaneously within a few months from disease onset, has been considered as a …
Efficacy of topical carbonic anhydrase inhibitors in reducing duration of chronic central serous chorioretinopathy
G Liew, IV Ho, S Ong, B Gopinath… - … Vision Science & …, 2020 - tvst.arvojournals.org
Purpose: Topical carbonic anhydrase inhibitors (CAIs) can influence retinal fluid distribution,
but their role in treating central serous chorioretinopathy (CSCR) has not been studied. We …
but their role in treating central serous chorioretinopathy (CSCR) has not been studied. We …